Iovance Biotherapeutics, Inc.
Expansion of tumor infiltrating lymphocytes with potassium channel agonists and therapeutic uses thereof

Abstract:

Methods of expanding tumor infiltrating lymphocytes (TILs) using a potassium channel agonist, such as a K.sub.Ca3.1 (IK channel) agonist, and uses of such expanded TILs in the treatment of diseases such as cancer are disclosed herein.